Katherine Arndtz1,2,3, Gideon M Hirschfield1,2,3. 1. National Institute for Health Research Birmingham Biomedical Research Centre, Birmingham, UK. 2. Institute of Immunology & Immunotherapy, University of Birmingham, Birmingham, UK. 3. Centre for Rare Diseases, Institute of Translational Medicine, Birmingham Health Partners, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham, UK.
Authors: Elena Marcus; Paddy Stone; Anna-Maria Krooupa; Douglas Thorburn; Bella Vivat Journal: Health Qual Life Outcomes Date: 2021-03-20 Impact factor: 3.186